,,iii  #aai? ,,congress  #a/ ,session   
,s4 ,,res4 #dfd  ,,9 ,,! ,,s5ate ,,( ,,!
 ,,unit$ ,,/ates  ,octob] #bc1          
#bjbe,mrs4 ,hyde-,smi? 7= h]self1 ,mr4  
,pet]s1 ,mr4 ,boozman1 ,mr4 ,m>%all1    
,mr4 ,da9es1 & ,mr4 ,padilla7 submitt$ !
 foll[+ resolution2 :i* 0 consid]$ &    
agre$ to  ,,resolution  ,designat+      
,septemb] #bjbe z ,national ,*ole/]ol   
,education ,mon? & ,septemb] #cj1 #bjbe1
 z ,,ldl-,c ,aw>5ess ,day4  ,:]eas      
c>diovascul> disease is ! lead+ cause ( 
dea? = m5 & wom5 9 ! ,unit$ ,/ates2     
,:]eas project$ rates ( c>diovascul>    
disease are expect$ to increase         
significantly 9 ! ,unit$ ,/ates by      
#bjfj2 ,:]eas1 comp>$ to urban areas1   
rural areas 9 ! ,unit$ ,/ates h high]   
dea? rates = c>diovascul> disease &     
/roke1 & a #dj p]c5t high] preval5ce (  
c>diovascul> disease2 ,:]eas risk       
factors contribut+ to c>diovascul>      
disease & poor heal? outcomes include   
elevat$ l[ d5sity lipoprote9 *ole/]ol   
7ref]r$ to 9 ?is preamble z ,,ldl-,c71  

high levels ( lipoprote97a7 *ole/]ol1   
hyp]t5sion1 obesity1 l[ aw>5ess (       
p]sonal risk factors1 g5etics1          
geographic location1 & inequitable      
access to c>e2 ,:]eas lipoprote97a7     
*ole/]ol is pr$om9antly g5etically      
inh]it$ & c build up 9 ! walls ( blood  
vessels1 creat+ *ole/]ol deposits1 or   
plaques1 & lead to a!roscl]otic         
c>diovascul> disease2 ,:]eas ,,ldl-,c is
 a modifiable risk factor = c>diovascul>
 disease1 & hav+ l[] ,,ldl-,c is        
associat$ ) a r$uc$ risk ( he>t attack &
 /roke2 ,:]eas m ?an #be4e p]c5t (      
adults 9 ! ,unit$ ,/ates h high         
,,ldl-,c2 ,:]eas m ?an #bjj /udies ) m  
?an #b1jjj1jjj pati5ts h broadly        
e/abli%$ t elevat$ ,,ldl-,c causes      
a!roscl]otic c>diovascul> disease2      
,:]eas a!roscl]otic c>diovascul> disease
 is ! build-up ( *ole/]ol plaque )9 !   
walls ( art]ies & includes acute coron>y
 syndrome1 p]iph]al art]ial disease1 &  
ev5ts su* z he>t attacks & /rokes2      
,:]eas ! res\rces ne$$ to b5d ! curve on

 c>diovascul> disease exi/1 yet #ga     
p]c5t ( hyp]*ole/]olemia pati5ts at high
 risk ( a c>diovascul> ev5t nev] a*ieve 
recomm5d$ ,,ldl-,c treatm5t guidel9e    
?re%olds2 ,:]eas only #cc p]c5t (       
individuals ) a!roscl]otic c>diovascul> 
disease :o are tak+ /at9s1 a guidel9e   
recomm5d$ lipid-l[]+ !rapy1 actually    
a*ieve ,,ldl-,c goals2 ,:]eas1 al?\gh   
cl9ical guidel9es recomm5d t a pati5t   
hospitaliz$ = he>t attack receive an    
,,ldl-,c te/ 9 ! #ij days foll[+ dis*>ge
 f a hospital1 only #bg p]c5t ( pati5ts 
receive ! te/2 ,:]eas ,african-,am]ican 
adults are less likely to receive an    
,,ldl-,c te/ 9 ! #ij days foll[+ dis*>ge
 f a hospital1 despite hav+ a high]     
preval5ce ( c>diovascul> disease2 ,:]eas
 significant gaps 9 c>e may lead to     
subsequ5t c>diovascul> ev5ts2 ,:]eas !  
,million ,he>ts program seeks to improve
 access to & quality ( c>e to r$uce he>t
 disease1 /roke1 & dea?2 & ,:]eas       
,septemb] is recogniz$ z ,national      
,*ole/]ol ,education ,mon? to raise     

aw>5ess ( c>diovascul> disease & !      
importance ( individuals kn[+ _!        
,,ldl-,c numb]3 ,n[1 !re=e1 be x ,t !   
,s5ate-- 7#a7 enc\rages all individuals 
9 ! ,unit$ ,/ates to "k _! l[ d5sity    
lipoprote9 *ole/]ol 7ref]r$ to 9 ?is    
resolution z ,,ldl-,c7 numb]2  7#b7     
designates ,septemb] #bjbe z ,national  
,*ole/]ol ,education ,mon?2  7#c7       
designates ,septemb] #cj1 #bjbe1 z      
,,ldl-,c ,aw>5ess ,day2 &  7#d7         
recognizes ! urg5t ne$ = scre5+ & treat+
 ( elevat$ ,,ldl-,c to r$uce ! risk (   
c>diovascul> disease & c>diovascul>     
ev5ts1 includ+ he>t attacks & /rokes4